Skip to content

Tazanolast

Drug profile

Also known as: tazalest, tazanol

Data last refreshed: (DrugCentral release 2024-11-01)

Key facts

Tazanolast is a drug catalogued in DrugCentral. Recorded indications include Allergic conjunctivitis.

  • Indications: Allergic conjunctivitis.
  • Molecular formula: C13H15N5O3; molecular weight 289.30 g/mol.

Indications & contraindications

Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).

Indications (1)

  • Allergic conjunctivitis

Chemical structure

Full physicochemical, ADMET and 3D-structure analysis of Tazanolast is on its molecule page.

Molecular formulaC13H15N5O3
Molecular weight289.30 g/mol
CAS number82989-25-1
InChIKeyXQTARQNQIVVBRX-UHFFFAOYSA-N
PubChem CID5380
CCCCOC(=O)C(=O)NC1=CC=CC(=C1)C1=NN=NN1

Frequently asked questions

Answers are generated from the structured data on this page, not written by hand.

What is Tazanolast used for?

DrugCentral lists the following indications for Tazanolast: Allergic conjunctivitis.

What is the chemical formula of Tazanolast?

Tazanolast has the molecular formula C13H15N5O3 and a molecular weight of 289.30 g/mol.

Browse: all drugs starting with T · drug guides by category · protein targets A–Z.

Sources

How this page is built: methodology · editorial policy & corrections.

For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.

Quick facts

Status—
First approval—
Agency—
Targets0
Indications1
FormulaC13H15N5O3
DrugCentral ID2570
Interactive profile